Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.39 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.39 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.39 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LPL | P06858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6065331 | 0.85 | CA12 (0.35) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL29249836 | 0.85 | CA12 (0.35) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL675958 | 0.84 | CA12 (0.57) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL1289919 | 0.82 | KDM4E (0.46) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL2884582 | 0.82 | CA1 (0.42) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL30006611 | 0.82 | KDM4E (0.46) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL5524 | 0.82 | ENPP2 (0.42) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL248795 | 0.82 | CA2 (0.42) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL31590081 | 0.82 | ENPP2 (0.42) | CA1CA12CA9ORAI1ORAI2 | |
| SCHEMBL1158717 | 0.82 | ENPP2 (0.38) | CA1ORAI1ORAI2ORAI3TRPV6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3207 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4330229-B1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2025-12-17 | — | — | EP | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-119798664-A | Preparation process of adsorption material for treating textile printing and dyeing industry wastewater | 广东江宇环保工程设备有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119330924-A | Preparation method of alkyl pyran 3, 5-difluorobenzene | 石家庄市凯信电子材料有限公司 | 2025-01-21 | — | — | CN | claimed |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-07-11 | — | — | US | claimed |
| EP-4330229-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2024-03-06 | — | — | EP | claimed |
| CN-117529470-A | Method for producing pyrrolidine compounds | 武田药品工业株式会社 | 2024-02-06 | — | — | CN | claimed |
| WO-2024016826-A1 | 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF | 杭州市第七人民医院 | 2024-01-25 | — | — | WO | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2081946-A2 | ADENOSINE DERIVATIVES FOR THE TREATMENT OF PAIN | Biovitrum AB (publ) (SE) | 2009-07-29 | — | — | EP | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| WO-2008000745-A2 | ADENOSINE DERIVATIVES FOR THE TREATMENT OF PAIN | BIOVITRUM AB (PUBL) (SE) | 2008-01-03 | — | — | WO | claimed |
| US-7037905-B2 | Pharmaceutical use of boronic acids and esters thereof | NOVO NORDISK A/S (DK) | 2006-05-02 | — | — | US | claimed |
| US-20040053889-A1 | Pharmaceutical use of boronic acids and esters thereof | NOVO NORDISK A/S (DK) | 2004-03-18 | — | — | US | claimed |
| WO-2003105860-A1 | PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF | NOVO NORDISK A/S (DK) | 2003-12-24 | — | — | WO | claimed |
| US-20030211138-A1 | Temperature control system for cutaneous photodynamic therapy | SPECTRA SYSTEMS CORPORATION | 2003-11-13 | — | — | US | claimed |
| WO-2003070315-A2 | TEMPERATURE CONTROL SYSTEM FOR CUTANEOUS PHOTODYNAMIC THERAPY | SPECTRA SYSTEMS CORPORATION (US) | 2003-08-28 | — | — | WO | claimed |